NASDAQ:TNYA
Tenaya Therapeutics
- Stock
Last Close
2.77
30/08 20:00
Market Cap
241.05M
Beta: -
Volume Today
257.84K
Avg: 560.72K
PE Ratio
−2.55
PFCF: −2.80
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 808.50K - | 5.87M 625.91% | 10.15M 72.93% | 7.60M 25.08% | ||
average receivables | ||||||
book value per share | -1.62 - | -2.99 85.05% | 15.71 625.36% | 5.43 65.43% | 0.00 99.97% | |
capex per share | -0.11 - | -0.36 232.12% | -1.42 294.65% | -0.46 67.51% | -0.00 100.00% | |
capex to depreciation | -1.47 - | -3.93 167.28% | -8.48 115.77% | -3.19 62.40% | -0.14 95.69% | |
capex to operating cash flow | 0.12 - | 0.28 126.82% | 0.41 49.98% | 0.20 52.18% | 0.01 93.86% | |
capex to revenue | ||||||
cash per share | 0.98 - | 4.73 380.53% | 14.17 199.87% | 4.16 70.63% | 0.00 99.97% | |
days of inventory on hand | ||||||
days payables outstanding | ||||||
days sales outstanding | ||||||
debt to assets | 0.05 - | 0.05 8.32% | 0.07 34.61% | |||
debt to equity | 0.06 - | 0.06 10.05% | 0.09 43.63% | |||
dividend yield | ||||||
earnings yield | -0.06 - | -0.09 47.92% | -0.21 125.89% | -1.37 562.25% | -0.00 99.96% | |
enterprise value | 391.72M - | 288.99M 26.23% | 311.64M 7.84% | 9.92M 96.82% | 239.03B 2,408,924.72% | |
enterprise value over ebitda | -15.23 - | -7.93 47.91% | -4.28 46.04% | -0.08 98.15% | -1.82K 2,306,609.16% | |
ev to operating cash flow | -16.26 - | -8.15 49.85% | -5.12 37.14% | -0.10 98.15% | -2.34K 2,464,434.82% | |
ev to sales | ||||||
free cash flow per share | -1.00 - | -1.66 66.53% | -4.85 191.53% | -2.79 42.42% | -0.00 99.95% | |
free cash flow yield | -0.07 - | -0.11 66.53% | -0.26 136.15% | -1.39 442.82% | -0.00 99.97% | |
graham net net | -2.04 - | -3.71 82.30% | 12.16 427.65% | -2.06 116.96% | 0.00 100.05% | |
graham number | 5.88 - | 9.73 65.45% | 37.25 282.76% | 18.36 50.72% | 0.01 99.95% | |
income quality | 0.92 - | 0.92 0.50% | 0.84 9.42% | 0.84 0.98% | 0.82 2.58% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | 64.22K - | |||||
interest debt per share | 0.89 - | 0.34 61.96% | 0.00 99.95% | |||
inventory turnover | ||||||
invested capital | 0.06 - | 0.06 10.05% | 0.09 43.63% | |||
market cap | 415.59M - | 417.52M 0.46% | 336.06M 19.51% | 90.10M 73.19% | 239.07B 265,248.70% | |
net current asset value | -54.00M - | -99.51M 84.29% | 219.69M 320.77% | -85.19M 138.78% | 80.49M 194.48% | |
net debt to ebitda | 0.93 - | 3.53 280.20% | 0.34 90.49% | 0.64 90.26% | 0.25 60.28% | |
net income per share | -0.95 - | -1.41 47.92% | -3.93 178.87% | -2.76 29.76% | -0.00 99.94% | |
operating cash flow per share | -0.89 - | -1.30 46.43% | -3.43 163.13% | -2.33 32.06% | -0.00 99.94% | |
payables turnover | ||||||
receivables turnover | ||||||
research and ddevelopement to revenue | ||||||
return on tangible assets | -0.68 - | -0.26 61.88% | -0.22 14.26% | -0.44 99.98% | -0.73 64.15% | |
revenue per share | ||||||
roe | 0.59 - | 0.47 20.06% | -0.25 153.08% | -0.51 103.19% | -0.89 75.15% | |
roic | 0.62 - | 0.48 23.32% | -0.23 147.43% | -0.46 102.77% | -0.80 73.93% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | -1.62 - | -2.99 85.05% | 15.71 625.36% | 5.43 65.43% | 0.00 99.97% | |
stock based compensation to revenue | ||||||
tangible asset value | -43.74M - | -81.31M 85.91% | 278.53M 442.53% | 139.42M - | ||
tangible book value per share | -1.62 - | -2.99 85.05% | 15.71 625.36% | 0.00 - | ||
working capital | 23.62M - | 124.92M 428.84% | 233.58M 86.98% | 169.51M 27.43% | 88.85M 47.58% |
All numbers in USD (except ratios and percentages)